Results 161 to 170 of about 1,251,059 (351)

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Medical Oncology Group of Australia Annual Scientific Meeting, August 2-4, 2023. [PDF]

Lancet Reg Health West Pac, 2023
Caga-Meller J.
europepmc   +1 more source

Higher training and continuing medical education in radiation oncology in the United Kingdom

, 1992
Richard G.B. Evans
openalex   +1 more source

Reply to the Letter to the Editor “Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelines”,by B. Fervers, T. Philip andG. P. Browman (Ann Oncol 2002; 13: 1507–1509) [PDF]

, 2002
Rolf A. Stahel
openalex   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

First impressions: A prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation. [PDF]

Cancer Med, 2023
Bach Y, Panov E, Espin-Garcia O, Chen E, Krzyzanowska M, O'Kane G, Moore M, Prince RM, Knox J, Grant R, Ma LX, Allen MJ, Eng L, Kosyachkova E, Megid TBC, Barron C, Wang X, Saltiel MP, Farooq ARR, Jang RW, Elimova E.   +20 more
europepmc   +1 more source

XV Congress of the European Society for Medical Oncology

, 1990

openalex   +1 more source

Benefits of psychosocial oncology care: improved quality of life and medical cost offset. [PDF]

, 2003
Linda E. Carlson, Barry D. Bultz
openalex   +1 more source

Enfermagem em unidade de transplante de células-tronco hematopoiéticas: o perfil e o cuidar de si [Nursing in a hematopoietic stem cell transplant unit: profile and self-care]

Revista Enfermagem UERJ, 2014
Estudo descritivo, com abordagem quantitativa, que objetivou identificar o perfil dos profissionais de enfermagem de uma unidade de transplante de células-tronco hematopoiéticas e ações utilizadas para o cuidar de si. Para sustentação teórica utilizou-se
Sandra Hilda Sobrinho, Vera Radünz, Luciana Martins da Rosa   +2 more
doaj  

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source